The Dual Antiplatelet Therapy Study (DAPT Study)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dean Kereiakes, MD, FACC
Christ Hospital Heart and Vascular Center
Principal Investigator - Laura Mauri, MD, MSc
Brigham and Women's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
256 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Vincents Hospital Sydney
Darlinghurst, New South Wales, Australia
- Prince of Wales Eastern Heart
Randwick, New South Wales, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- the Alfred Hospital
Prahran, Victoria, Australia
- Fremantle Hospital
Fremantle, Western Australia, Australia
- the Mount Hospital
Nedlands, Western Australia, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- Monash Heart
Clayton, Australia
- St Vincents Hospital Melbourne
Fitzroy, Australia
- Fakultni Nemocnice Hradec Kralove
Hradec Králové, Czechia
- Krajska Karlovarska Nemocnice A.S.
Karlovy Vary, Czechia
- Centrum Pro Choroby Srdce A Cev
Kroměříž, Czechia
- Mestska Nemocnice Ostrava
Ostrava, Czechia
- Krajska Nemocnice T. Bati A.S.
Zlín, Czechia
- Centre Hospitalier Saint Louis
La Rochelle, France
- Hospital Saint Philibert
Lomme, France
- Nouvelles Cliniques Nantaises
Nantes, France
- Clinique Les Franciscaines
Nîmes, France
- Hopital Bichat
Paris, France
- Groupe Hospitalier Sud
Pessac, France
- Ch Chatiliez Tourcoing
Tourcoing, France
- Universitaetsklinikum Schleswig-Holstein - Ps
Lübeck, Schleswig-Holstein, Germany
- Helios Klinikum Emil Von Behring
Berlin, State of Berlin, Germany
- Vivantes Klinikum Im Friedrichshain
Berlin, Germany
- Vivantes-Humboldt Klinikum
Berlin, Germany
- Vivantes-Klinikum Neukoelin
Berlin, Germany
- Vivantes-Klinikum Neukoelln
Berlin, Germany
- Elbe-Kliniken Stade-Buxtehude Gmbh
Buxtehude, Germany
- Universitaetsklinikum Dresden
Dresden, Germany
- Asklepios Klinik St. Georg
Hamburg, Germany
- Herzzentrum Leipzig Gmbh
Leipzig, Germany
- Elbe-Kliniken Stade-Buxtehude Gmbh
Stade, Germany
- Gottsegen Gyorgy Orszagos Kardiologiai Intezet
Budapest, Hungary
- Josa Andras Oktato Korhaz Nonprofit Kft
Nyíregyháza, Hungary
- Pecsi Tudomanyegyetem Klinikai Kozpont
Pécs, Hungary
- Szegedi Tudomanyegyetem Szent-Gyorgyi Klinikai Kozpont
Szeged, Hungary
- Zala Megyei Korhaz
Zalaegerszeg, Hungary
- Mercy Angiography
Epsom, Auckland, New Zealand
- Ascot Hospital
Auckland, New Zealand
- Middlemore Hospital
Auckland, New Zealand
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 30 Jun 2014
- Completion
- 30 Jun 2014
- Last update posted
- 9 Jun 2017
- Registered enrollment
- 25,682
- Registry id
- NCT00977938
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.